跳至主要内容
临床试验/IRCT20200831048569N1
IRCT20200831048569N1招募中3 期

The effect of Vitagnus tablets on follicle number and size, endometrial thickness and fertility in infertile women with polycystic ovary syndrome

Gonabad University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 35 years(—)
性别
Female

入选标准

  • Age 18 to 35 years
  • Having written consent to participate in the study
  • Infertility is known to cause polycystic ovary syndrome and rule out other causes of infertility
  • Ultrasound-confirmed polycystic ovaries along with another Rotterdam criteria
  • No other androgenic disorders such as adrenal hyperplasia or androgen-producing tumor
  • Manifestations of hyperandrogenism (high testosterone)
  • No diseases such as: hypothyroidism or hyperthyroidism, hyperprolactinemia, kidney, heart, liver, bone diseases, pituitary tumor, cancer and diabetes
  • Do not take infertility drugs or any other hormonal drugs in the last three months
  • Body mass index 18 to 35
  • Hypersensitivity to food and drugs such as lactose, letrozole and vitagnus

排除标准

  • Breastfeeding
  • Smoking and drugse
  • Stressful events in the last three months
  • Previous surgery on one or both ovaries
  • Taking haloperidol

研究者

发起方
Gonabad University of Medical Sciences

相似试验